MayTech Global Investments’s PTC Therapeutics PTCT Stock Holding History

MayTech Global Investments’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-145	Closed	-$5.54K	–	51
2022 Q4	$5.54K	Buy	+145	New	+$6.03K	﹤0.01%	61
2022 Q3	–	Sell	-145	Closed	-$6K	–	61
2022 Q2	$6K	Hold	145	–	–	﹤0.01%	69
2022 Q1	$5K	Hold	145	–	–	﹤0.01%	74
2021 Q4	$6K	Hold	145	–	–	﹤0.01%	78
2021 Q3	$5K	Hold	145	–	–	﹤0.01%	65
2021 Q2	$6K	Hold	145	–	–	﹤0.01%	63
2021 Q1	$7K	Hold	145	–	–	﹤0.01%	53
2020 Q4	$9K	Hold	145	–	–	﹤0.01%	52
2020 Q3	$7K	Hold	145	–	–	﹤0.01%	48
2020 Q2	$7K	Hold	145	–	–	﹤0.01%	49
2020 Q1	$6K	Hold	145	–	–	﹤0.01%	48
2019 Q4	$7K	Hold	145	–	–	﹤0.01%	47
2019 Q3	$5K	Hold	145	–	–	﹤0.01%	43
2019 Q2	$7K	Hold	145	–	–	﹤0.01%	43
2019 Q1	$5K	Hold	145	–	–	﹤0.01%	43
2018 Q4	$5K	Buy	+145	New	+$5.21K	﹤0.01%	43

Other funds holding PTCT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

MayTech Global Investments's PTCT Position: Q1 2023 in Review

MayTech Global Investments sold out of PTC Therapeutics (PTCT) in Q1 2023, closing a stake of 145 shares — an estimated $5.54K sold.

MayTech Global Investments first reported a position in PTCT in Q4 2018 and held it in 16 quarters. The position peaked at $9K in Q4 2020. 202 funds tracked by Wall St. Rank hold PTCT as of Q1 2023.

MayTech Global Investments reported no remaining PTC Therapeutics position as of Q1 2023 after selling out during the quarter.
MayTech Global Investments sold 145 PTC Therapeutics shares in Q1 2023, an estimated $5.54K.
MayTech Global Investments first reported a position in PTC Therapeutics in Q4 2018 and held it in 16 quarters.
MayTech Global Investments's PTC Therapeutics position peaked at $9K in Q4 2020.
202 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2023.

Based on MayTech Global Investments's 13F filing for Q1 2023, filed 11 May 2023.